Skip to Main content Skip to Navigation
Journal articles

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients

H. Le Guillou-Guillemette 1, * A. Ducancelle 1 S. Bertrais 2 C. Lemaire 1 A. Pivert 1 P. Veillon 1 E. Bouthry 1 S. Alain 3 Valérie Thibault 4 Florence Legrand-Abravanel 5, 6 A. R. Rosenberg 7 C. Henquell 8 E. André-Garnier 9 O. Petsaris 10 S. Vallet 10 J. B. Bour 11 Y. Baazia 12 P. Trimoulet 13 P. André 14 C. Gaudy-Graffin 15 D. Bettinger 16 Sylvie Larrat 17 A. Signori-Schmuck 18 H. Saoudin 19 B. Pozzetto 19 G. Lagathu 20 S. Minjolle-Cha 20 F. Stoll-Keller 21 J. M. Pawlotsky 22 Jacques Izopet 5, 6 C. Payan 10 F Lunel-Fabiani 1
Abstract : Background The NS5A protein of the hepatitis C virus has been shown to be involved in the development of hepatocellular carcinoma. Objectives In a French multicenter study, we investigated the clinical and epidemiological features of a new HCV genotype 1b strain bearing a wide insertion into the V3 domain. Study Design We studied NS5A gene sequences in 821 French patients infected with genotype 1b HCV. Results We identified an uncharacterized V3 insertion without ORF disruption in 3.05% of the HCV sequences. The insertion comprised 31 amino-acids for the majority of patients; 3 patients had 27 amino-acids insertions and 1 had a 12 amino-acids insertion. Sequence identity between the 31 amino-acids insertions and the V3 domain ranged from 48 to 96% with E-values above 4e-5, thus illustrating sequence homology and a partial gene duplication event that to our knowledge has never been reported in HCV. Moreover we showed the presence of the duplication at the time of infection and its persistence at least during 12 years in the entire quasispecies. No association was found with extrahepatic diseases. Conversely, patients with cirrhosis were two times more likely to have HCV with this genetic characteristic (p=0.04). Moreover, its prevalence increased with liver disease severity (from 3.0% in patients without cirrhosis to 9.4% in patients with both cirrhosis and HCC, p for trend=0.045). Conclusions We identified a duplicated V3 domain in the HCV-1b NS5A protein for the first time. The duplication may be associated with unfavorable evolution of liver disease including a possible involvement in liver carcinogenesis
Document type :
Journal articles
Complete list of metadata

Cited literature [25 references]  Display  Hide  Download
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Wednesday, November 25, 2015 - 9:34:16 AM
Last modification on : Tuesday, January 11, 2022 - 5:56:29 PM
Long-term archiving on: : Friday, February 26, 2016 - 12:13:17 PM


Identification of a duplicated...
Files produced by the author(s)



H. Le Guillou-Guillemette, A. Ducancelle, S. Bertrais, C. Lemaire, A. Pivert, et al.. Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients. Journal of Clinical Virology, Elsevier, 2015, 69, pp.203-209. ⟨10.1016/j.jcv.2015.06.096⟩. ⟨hal-01231431⟩



Les métriques sont temporairement indisponibles